All > Bipolar Disorder

e-CBT for Bipolar Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Bipolar Disorder+1 Moree-CBT - Behavioral
Eligibility
18 - 55
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to study the feasibility and effectiveness of e-CBT for treating patients with bipolar II disorder who have residual depressive symptoms.

Eligible Conditions
  • Bipolar Disorder
  • Depression, Bipolar Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Interferon gamma-primed mesenchymal stromal cells (MSCs)
1
Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
1
Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Baseline, week 6, week 12

Week 12
Change in symptoms (Modified Clinical Global Impression Scale for Bipolar Disorder - CGI-BP-M)
Change in symptoms (Montgomery Asberg Depression Rating Scale - MADRS)
Change in symptoms (Young Mania Rating Scale - YMRS)
Week 12 (Post-Treatment)
Differences in personal, social, and cultural factors impacting accessibility to treatment

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Interferon gamma-primed mesenchymal stromal cells (MSCs)
1
Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
1
Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells

Trial Design

2 Treatment Groups

Treatment as Usual
1 of 2
e-CBT
1 of 2

Active Control

Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: e-CBT · No Placebo Group · N/A

e-CBT
Behavioral
Experimental Group · 1 Intervention: e-CBT · Intervention Types: Behavioral
Treatment as UsualNoIntervention Group · 1 Intervention: Treatment as Usual · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-CBT
2021
N/A
~120

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, week 6, week 12

Who is running the clinical trial?

Queen's UniversityLead Sponsor
336 Previous Clinical Trials
110,868 Total Patients Enrolled
6 Trials studying Bipolar Disorder
397 Patients Enrolled for Bipolar Disorder
Online PsychoTherapy ClinicOTHER
8 Previous Clinical Trials
566 Total Patients Enrolled
Nazanin AlaviPrincipal InvestigatorQueen's University
5 Previous Clinical Trials
386 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top